PUBLISHER: TechSci Research | PRODUCT CODE: 1732958
PUBLISHER: TechSci Research | PRODUCT CODE: 1732958
Hereditary Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type, By Technology, By Region and Competition, 2020-2030F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Hereditary Testing Market was valued at USD 6.54 billion in 2024 and is projected to reach USD 10.26 billion by 2030, growing at a CAGR of 7.79% during the forecast period. Hereditary testing has significantly transformed modern healthcare by enabling the detection, diagnosis, and prevention of numerous inherited conditions. Also known as genetic or DNA testing, this process involves examining an individual's DNA to identify mutations linked to hereditary diseases. Applications range from diagnosing conditions like cystic fibrosis and certain cancers to informing family planning and tailoring drug therapies based on individual genetic profiles. The surge in awareness around genetic health, supported by rapid advancements in genomics and biotechnology, is driving widespread adoption. In addition to clinical utility, many consumers are leveraging hereditary testing to explore ancestry and understand genetic heritage, contributing to broader market expansion.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 6.54 Billion |
| Market Size 2030 | USD 10.26 Billion |
| CAGR 2025-2030 | 7.79% |
| Fastest Growing Segment | Hereditary Cancer Testing |
| Largest Market | North America |
Key Market Drivers
Increasing Prevalence of Genetic Disorders is Driving Global Hereditary Testing Market
The rising incidence of genetic disorders is a primary force behind the growth of the hereditary testing market. As the global population ages, the likelihood of developing hereditary conditions increases, prompting a need for early detection and proactive healthcare. Enhanced research and discovery of genetic markers are broadening the spectrum of diseases for which testing is recommended. Prospective parents are increasingly turning to carrier screening to identify potential hereditary risks to their children, fostering informed reproductive choices. Additionally, genetic testing is gaining traction in assessing susceptibility to hereditary cancers such as breast and colon cancer, enabling timely preventive actions and regular screenings. The expanding understanding of genetics and heightened public awareness are fueling demand for these tests, positioning hereditary testing as a cornerstone of modern personalized medicine.
Key Market Challenges
Ethical and Privacy Concerns
One of the major challenges in the hereditary testing market is the ethical and privacy concerns surrounding genetic data. Individuals are often wary of how their sensitive genetic information is collected, stored, and shared. Risks such as data breaches, unauthorized access, and potential discrimination by employers or insurers create apprehension among users. This has led to increasing calls for stricter data protection laws and transparent policies that ensure confidentiality and responsible usage of genetic information. Addressing these concerns is essential for maintaining public trust and encouraging broader adoption of hereditary testing services.
Key Market Trends
Technological Advancements
The hereditary testing market is being rapidly transformed by technological innovations that are enhancing the speed, affordability, and scope of genetic analysis. One of the most impactful advancements is the widespread adoption of Next-Generation Sequencing (NGS), which allows for efficient and cost-effective sequencing of entire genomes or specific gene panels. This has significantly expanded testing capabilities, making it possible to detect rare mutations and gain deeper insights into genetic predispositions. Additionally, the integration of big data analytics and advanced bioinformatics has revolutionized the interpretation of complex genetic data. These tools enable healthcare providers to identify meaningful patterns and correlations, improving diagnostic accuracy and enabling more precise treatment plans. As these technologies evolve, they are expected to drive further innovation and accessibility in the hereditary testing landscape.
Key Market Players
- Myriad Genetics, Inc.
- Illumina, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
- COOPERSURGICAL, INC.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- SOPHiA GENETICS
Report Scope:
In this report, the Global Hereditary Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Hereditary Testing Market, By Disease Type:
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
Hereditary Testing Market, By Technology:
- Cytogenetic
- Biochemical
- Molecular Testing
Hereditary Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Hereditary Testing Market.
Available Customizations:
Global Hereditary Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
4. Voice of Customer
5. Global Hereditary Testing Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing)
- 5.2.2. By Technology (Cytogenetic, Biochemical, Molecular Testing)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Market Map
6. North America Hereditary Testing Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Disease Type
- 6.2.2. By Technology
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Hereditary Testing Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Disease Type
- 6.3.1.2.2. By Technology
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Hereditary Testing Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Disease Type
- 6.3.2.2.2. By Technology
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Hereditary Testing Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Disease Type
- 6.3.3.2.2. By Technology
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Hereditary Testing Market Outlook
7. Europe Hereditary Testing Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Disease Type
- 7.2.2. By Technology
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Hereditary Testing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Disease Type
- 7.3.1.2.2. By Technology
- 7.3.1.1. Market Size & Forecast
- 7.3.2. United Kingdom Hereditary Testing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Disease Type
- 7.3.2.2.2. By Technology
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Italy Hereditary Testing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Disease Type
- 7.3.3.2.2. By Technology
- 7.3.3.1. Market Size & Forecast
- 7.3.4. France Hereditary Testing Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Disease Type
- 7.3.4.2.2. By Technology
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Hereditary Testing Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Disease Type
- 7.3.5.2.2. By Technology
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Hereditary Testing Market Outlook
8. Asia-Pacific Hereditary Testing Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Disease Type
- 8.2.2. By Technology
- 8.2.3. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Hereditary Testing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Disease Type
- 8.3.1.2.2. By Technology
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Hereditary Testing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Disease Type
- 8.3.2.2.2. By Technology
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Hereditary Testing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Disease Type
- 8.3.3.2.2. By Technology
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Hereditary Testing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Disease Type
- 8.3.4.2.2. By Technology
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Hereditary Testing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Disease Type
- 8.3.5.2.2. By Technology
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Hereditary Testing Market Outlook
9. South America Hereditary Testing Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Disease Type
- 9.2.2. By Technology
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Hereditary Testing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Disease Type
- 9.3.1.2.2. By Technology
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Hereditary Testing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Disease Type
- 9.3.2.2.2. By Technology
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Hereditary Testing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Disease Type
- 9.3.3.2.2. By Technology
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Hereditary Testing Market Outlook
10. Middle East and Africa Hereditary Testing Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Disease Type
- 10.2.2. By Technology
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Hereditary Testing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Disease Type
- 10.3.1.2.2. By Technology
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Hereditary Testing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Disease Type
- 10.3.2.2.2. By Technology
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Hereditary Testing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Disease Type
- 10.3.3.2.2. By Technology
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Hereditary Testing Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition
- 12.2. Product Development
- 12.3. Recent Developments
13. Global Hereditary Testing Market: SWOT Analysis
14. Competitive Landscape
- 14.1. Myriad Genetics, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Illumina, Inc.
- 14.3. Natera, Inc.
- 14.4. Laboratory Corporation of America Holdings
- 14.5. F. Hoffmann-La Roche Ltd.
- 14.6. Quest Diagnostics Incorporated
- 14.7. COOPERSURGICAL, INC.
- 14.8. Agilent Technologies, Inc.
- 14.9. Thermo Fisher Scientific, Inc.
- 14.10. SOPHiA GENETICS
15. Strategic Recommendations
16. About Us & Disclaimer
